Metabolomics and machine learning for early diagnosis of leptomeningeal metastasis: Caution before clinical application
Neuro-Oncology · 01.06.2026 · 28 (6) · 1588-1589
DOI: 10.1093/neuonc/noag048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 07.03.2026. Verfasst von Ryan G Rilinger und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine, Case Western Reserve University (R.G.R., A.D.). Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Cleveland Clinic Lerner College of Medicine, Case Western Reserve University (R.G.R., A.D.).
- Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic (R.G.R., A.D.).
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland Clinic (R.G.R., A.D.).
ORCID-Profile: Ryan G Rilinger, Andrew Dhawan
Zitieren
APA
Rilinger, R. G., & Dhawan, A. (2026). Metabolomics and machine learning for early diagnosis of leptomeningeal metastasis: Caution before clinical application. Neuro-Oncology, 28(6), 1588-1589. https://doi.org/10.1093/neuonc/noag048
Vancouver
Rilinger RG, Dhawan A. Metabolomics and machine learning for early diagnosis of leptomeningeal metastasis: Caution before clinical application. Neuro-Oncology. 2026;28(6):1588-1589. doi:10.1093/neuonc/noag048
BibTeX
@article{Rilinger2026,
author = {Rilinger, Ryan G and Dhawan, Andrew},
title = {Metabolomics and machine learning for early diagnosis of leptomeningeal metastasis: Caution before clinical application},
journal = {Neuro-Oncology},
year = {2026},
volume = {28},
number = {6},
pages = {1588--1589},
doi = {10.1093/neuonc/noag048}
}
EUVIMED